An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease

Mise à jour : Il y a 4 ans
Référence : NCT01118325

Femme et Homme

Extrait

The purpose of the study is to determine the drug characteristics of Ticagrelor, and to determine if 4 weeks treatment will reduce the blood clotting.


Critère d'inclusion

  • Stable Coronary Artery Disease

Liens